Psychotherapy and pharmacotherapy. A survey of combination treatment of neurotic and personality disorders;Psychotherapie und pharmakotherapie. Eine ubersicht zur kombinationsbehandlung bei neurotischen und personlichkeitsstorungen

Psychotherapeut

Volumn 43, Issue 6, 1998, Pages 331-351

  Kapfhammer, Hans Peter ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Anxiety disorders; Borderline personality disorder; Combination treatment; Depressive disorder; Obsessive compulsive disorder; Personality disorders; Pharmacotherapy; Psychotherapy

Indexed keywords

ALPRAZOLAM; CLOMIPRAMINE; DIAZEPAM; FLUVOXAMINE; IMIPRAMINE; LORAZEPAM; PAROXETINE;

ANXIETY NEUROSIS; BORDERLINE STATE; COUNTER TRANSFERENCE; NEUROSIS; OBSESSION; PATIENT COMPLIANCE; PERSONALITY DISORDER; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; REVIEW; TRANSFERENCE; TREATMENT INDICATION;

EID: 0031771760     PISSN: 09356185     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002780050134     Document Type: Review

References (219)

1. Adelman S (1985) Pills as transitional objects: A dynamic understanding of the use of medication in psychotherapy. Psychiatry 48:246-253
2. Ahrens S (Hrsg) (1997) Lehrbuch der psychotherapeutischen Medizin. Schattauer, Stuttgart New York
3. Balint M (1964) Der Arzt, sein Patient und die Krankheit. Klett-Cotta, Stuttgart
4. Bandelow B, Broocks A (1997) Die medikamentöse Behandlung der sozialen Phobie. In: Buchheim P (Hrsg) Psychotherapie und Psychopharmaka. Störungsorientierte Behandlungsansätze - kombinierte Therapie. Schattauer, Stuttgart New York, S 103-113
5. Barlow DH (1988) Anxiety and its disorders: The nature and treatment of anxiety and panic. Guilford Press, New York
6. Barlow DH, Craske MG, Cerny JA, Klosko JS (1989) Behavioral treatment of panic disorder. Behav Ther 20:261-282
7. Barron JW, Shands H (eds) (1996) Impact of managed care on psychodynamic treatment. International Univ Press, Madison, CT
8. Bradley SS (1990) Nonphysician psychotherapist-physician pharmacotherapist: A new model for concurrent treatment. Psychiat Clin North America 13:307-322
9. Beaudry P (1991) Generalized anxiety disorder. In: Beitman BD, Klerman GL (eds) Integrating pharmacotherapy and psychotherapy. Am Psychiatric Press, Washington, DC, London, pp 211-230
10. Beck AT, Sokol L, Clark D, Berchik R, Wright F (1992) A crossover study of focused cognitive therapy for panic disorder. Am J Psychiatry 149:778-783
11. Beitman BD (1993) Pharmacotherapy and the stages of psychotherapeutic change. In: Oldham JM, Riba MB, Tasman A (eds) Review of psychiatry, vol 12. Am Psychiatric Press, Washington, DC, London, pp 521-539
12. Beitman BD (1996) Integrating pharmacotherapy and psychotherapy: An emerging field of study. Bull Menninger Clin 60:160-173
13. Bemporad JR (1989) Intensive psychotherapy and psychoanalysis. In: Treatments of psychiatric disorders, vol 3. Am Psychiatric Press, Washington, DC, London, pp 1824-1833
14. Blackburn I, Bishop S, Glen AIM et al (1981) The efficacy of cognitive therapy in depression: A treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry 139:181-189
15. Blatt SJ (1992) The differential effect of psychotherapy and psychoanalysis with anaclitic and introjective patients: The Menninger Psychotherapy Research Project revisited. J Am Psychoanal Assoc 40:691-724
16. Blatt SJ (1995) The destructiveness of perfectionism. Implications for the treatment of depression. Am Psychol 12:1003-1020
17. Blatt SJ, Quinlan DM, Pilkonis PA, Shea MT (1995) Impact of perfectionism and need for approval on the brief treatment of depression:The National Institute of Mental Health treatment of depression collaborative research program revisited. J Consult Clin Psychol 63:125-132
18. Boerner RJ, Möller HJ (1998) Zum Stellenwert von Kombinationstherapien bei Angststörungen. Nervenheilkunde (im Druck)
19. Book HE (1983) Some psychodynamics of non-compliance. Can J Psychiatry 32:115-117
20. Bradley SS (1990) Nonphysician psychotherapist-physician pharmacotherapist: A new model for concurrent treatment. Psychiat Clin North America 13:307-322
21. Bruce TJ, Speigel DA, Gregg SF, Nuzzarello A (1995) Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. Am J Psychiatry 152:1156-1160
22. Buchheim P (1997) Psychotherapie und Psychopharmaka. Störungsorientierte Behandlungsansätze - kombinierte Therapie. Schattauer, Stuttgart New York
23. Busch F, Cooper A, Klerman GL et al (1991) Neurophysiological, cognitive-behavioral, and psychoanalytic approaches to panic disorder:Toward an integration. Psychoanal Inq 11:316-332
24. Busch F, Milrod B, Cooper A, Shapiro T (1996) Psychodynamic approaches to panic disorder. J Psychother Pract Res 5:73-83
25. Busch FN, Auchincloss EL (1995) The psychology of prescribing and taking medication. In: Schwartz HJ (ed) Psychodynamic concepts in general psychiatry. Am Psychiatric Press, Washington, DC, London, pp 401-416
26. Busch FN, Gould E (1993) Treatment by a psychotherapist and a psychopharmacologist:Transference and countertransference issues. Hosp Comm Psychiatry 8:772-774
27. Butler G, Fennell M, Robson P, Gelder M (1991) Comparison of behavior therapy and cognitive behavior therapy in the treatment of generalized anxiety disorder. J Consult Clin Psychol 59:167-175
28. Clark DM, Salkovskis PM, Hackmann A, Middleton H, Pavlos A, Gelder M (1994) A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 164:759-769
29. Clarkin JF, Hull J, Yeomans FE, Kakuma T, Cantor J (1994) Antisocial traits as measure of treatment response in borderline patients. J Psychother Pract Res 3:307-312
30. Clarkin JF, Koenigsberg HW, Yeomans F, et al (1992) Psychodynamic psychotherapy of the borderline patient. In: Clarkin JF, Marziali E, Bloom H (eds) Borderline personality disorder: Clinical and Empirical Perspectives. Guilford Press, New York, pp 268-287
31. Conte HR, Plutchik R, Wild KV, Karasu TB (1986) Combined psychotherapy and pharmacotherapy for depression. Arch Gen Psychiatry 43:471-479
32. Cooper AM (1985) Will neurobiology influence psychoanalysis? Am J Psychiatry 142:1395-1402
33. Cottraux J, Mollard E, Bouvard M, Marks IM, Sluys M, Nury AM, Douge R, Cialda P (1990) A controlled study of fluvoxamine and exposure in obsessive compulsive disorder. Int Clin Psychopharm 5:17-30
34. Covi L, Lipman RS (1987) Cognitive-behavioral group psychotherapy combined with imipramine in major depression. Psychopharmacol Bull 23:173-176
35. Craske MG (1988) Cognitive behavioral treatment of panic. Ann Rev Psychiatry 7:121-137
36. Craske MG, Brown TA, Barlow DH (1991) Behavioral treatment of panic disorder: A two-year follow-up. Behav Ther 22:289-304
37. Danckwardt JF (1978) Zur Interaktion von Psychotherapie und Psychopharmakotherapie. Psyche 32:111-154
38. Danckwardt JF (1979) Anmerkungen zur Indikation und Kontraindikation für die gleichzeitige Verwendung von psychoanalytischer Psychotherapie und Psychopharmakotherapie. Psyche 33:528-544
39. Danckwardt JF (1980) Psychopharmaka - ein Problem für Psychotherapeuten? Prax Psychother Psychosom 25:99-113
40. De Beurs E, van Balkom A, Lange A, Koele P, van Dyck R (1995) Treatment of panic disorder with agoraphobia: Comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. Am J Psychiatry 152:683-691
41. DiMascio A, Weissman MM, Prusoff BA (1979) Differential symptom reduction by drugs and psychotherapy in acute depression. Arch Gen Psychiatry 36:1450-1456
42. Dobson K (1989) A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol 57:414-419
43. Duggan C (1996) Behaviour therapy and drug treatments for obsessive-compulsive disorder. Adv Psychiat Treat 2:86-92
44. Dupont RL, Rice DP, Miller LS, et al (1995) Economic costs of obsessive-compulsive disorder. Med Interface 8:102-109
45. Edelman RE, Chambless DL (1993) Compliance during sessions and homework in exposure-based treatment of agoraphobia. Behav Res Ther 31:767-773
46. Elkin I, Shea T, Watkins JT, et al (1989) National Institute of Mental Health Treatment of Depression Collaborative Research Program: General effectiveness of treatments. Arch Gen Psychiatry 46:971-982
47. Elkin J (1994) The NIMH treatment of depression collaborative research program:where we began and where we are. In: Handbook of psychotherapy and behavior change, 4th edn. In: Bergin AE, Garfield SL (eds) Wiley & Sons, New York, pp 114-139
48. Engel GL (1977) The need for a new medical model: A challenge to biomedicine. Science 196:129-136
49. Esman AH (1985) Psychoanalysis and general psychiatry: Obsessive-compulsive disorder as paradigm. J Am Psychoanal Assoc 37:319-336
50. Evans M, Hollon S, DeRubeis R et al (1992) Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 49:802-808
51. Fava GA, Grandi S, Zielezny M, et al (1994) Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry 151:1295-1299
52. Fava GA, Zielezny M, Savron G, Grandi S (1995) Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry 166:87-92
53. Foa EB, Kozak MJ, Steketee GS, McCarthy PR (1992) Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy. Br J Clin Psychol 31:279-292
54. Foa EB, Steketee GS, Ozarow BJ (1985) Behavior therapy with obsessive-compulsives. From theory to treatment. In: Mavissakalian MR, Turner SM, Michelson L (eds) Obsessive-compulsive disorder: Psychological and pharmacological treatment. Plenum Press, New York, pp 49-129
55. Frank E, Kupfer DJ, Perel JM (1989) Early recurrence in unipolar depression. Arch Gen Psychiatry 46:397-400
56. Frank E, Kupfer DJ, Perel JM (1990) Three-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47:1093-1099
57. Frank E, Kupfer DJ, Wagner EF et al (1991) Efficacy of interpersonal psychotherapy as a maintenance treatment of reccurrent depression. Arch Gen Psychiatry 48:1053-1059
58. Freud S (1895) Entwurf einer Psychologie. GW Nachtragsband, S 387-477
59. Freud S (1919):Wege der psychoanalytischen Therapie. GW Bd 12, S183-194
60. Freud S (1938) Die psychoanalytische Technik. GW Bd 17, S 63-138
61. Gabbard GO (1992) Psychodynamic psychiatry in the "decade of the brain". Am J Psychiatry 149:991-998
62. Gabbard GO (1994a) Mind and brain in psychiatric treatment. Bull Menninger Clin 58:427-446
63. Gabbard GO (1994b) Psychodynamic psychiatry in clinical practice: The DSM-IV edition. American Psychiatric Press, Washington, DC, London
64. Gabbard GO (1998) The cost effectiveness of treating depression. Psychiatr Ann 28:98-101
65. Gelernter CS, Uhde TW, Cimbolic P, et al (1991) Cognitive-behavioral and pharmacological treatment for social phobia:A preliminary study. Arch Gen Psychiatry 48:938-945
66. Glen J (1988) A parameter. Ann Psychoanal 16:217-230
67. Goisman RM, Warshaw MG, Peterson LG et al (1994) Panic, agoraphobia, and panic disorder with agoraphobia. Data from a multicenter anxiety disorders study. J Nerv Ment Dis 182:72-79
68. Grawe K, Donati R, Bernauer F (1994) Psychotherapie im Wandel. Von der Konfession zur Profession. Hogrefe, Göttingen
69. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC (1995) Efficacy of drug treatment in obsessive-compulsive disorder: A metaanalytic review. Arch Gen Psychiatry 52:53-60
70. Gunderson JG (1984) Borderline personality disorder. Am Psychiatric Press, Washington, DC, London
71. Gunderson JG, Frank AG, Ronningstam EF, et al (1989) Early discontinuance of borderline patients from psychotherapy. J Nerv Ment Dis 177:38-42
72. Gutheil TG (1977) Improving patient compliance: Psychodynamics in drug prescribing. Drug Therapy 7:35-40
73. Gutheil TG (1978) Drug therapy: Alliance and compliance. Psychosomatics 19:219-225
74. Gutheil TG (1982) The psychology of psychopharmacology. Bull Menninger Clin 46:321-330
75. Hand I (1994) Verhaltenstherapie und/oder Pharmakotherapie bei Depressionen? Kritische Anmerkungen zu publizierten Therapievergleichsstudien. Fortschr Neurol Psychiat (Sonderheft 1) 62:44-52
76. Hand I (1995) Ambulante Verhaltenstherapie bei Zwangsstörungen. Fortschr Neurol Psychiat (Sonderheft) 63:12-18
77. Hautzinger M (1993) Kognitive Verhaltenstherapie und Pharmakotherapie bei Depressionen: Überblick und Vergleich. Verhaltenstherapie 3:26-34
78. HautzingerM (1995) Psychotherapie und Pharmakotherapie bei Depressionen. Psychotherapeut 40:373-380
79. Hautzinger M, deJong-Meyer R, Treiber R, Rudolf GAE, Thien U (1996) Wirksamkeit kognitiver Verhaltenstherapie, Pharmakotherapie und deren Kombination bei nicht-endogenen, unipolaren Depressionen. Z Klin Psychol 25 (2) (Themenheft)
80. Heimberg RG, Hope DA, Dodge CS, Becker RE (1980) DSM-III-R subtypes of social phobia. J Nerv Ment Dis 178:172-179
81. Hoffmann SO, Bassler M (1995) "Manual" für fokal orientierte psychoanalytische Psychotherapie bei Angststörungen. Erste Erfahrungen aus einer Therapiestudie. Forum Psychoanal 11:2-14
82. Hohagen F, König A, Raschke-Räuchle H, Hand I, Rey E (1997) Behavior therapy and fluvoxamine versus behavior therapy and placebo: Results of a multi-center study. Biol Psychiatry 42:139S
83. Hollon SD, DeRubeis RJ, Seligman MEP (1992) Cognitive therapy and the prevention of depression. Applied Prevent Psychol 1:89-95
84. Hollon SD, Fawcett J (1995) Combined medication and psychotherapy. In: Gabbard GO (ed) Treaments of psychiatric disorders, 2nd ed. Am Psychiatric Press, Washington, DC, London, pp 1221-1236
85. Hollon SD, Shelton RC, Loosen PT (1991) Cognitive therapy and pharmacotherapy for depression. J Consult Clin Psychol 59:88-99
86. Howard EB (1987) Some psychodynamics of noncompliance. Can J Psychiatry 32:115-117
87. Hyland JM (1991) Integrating psychotherapy and pharmacotherapy. Menninger Clinic 55:205-215
88. Imber SD, Pilkonis PA, Sotsky SM et al (1990) Mode-specific effects among three treatments for depression. J Consult Clin Psychol 58:352-359
89. Jefferson JW, Greist JH (1996) The pharmacotherapy of obsessive-compulsive disorder. Psychiatr Ann 26:202-209
90. Jenike M (1990) Approaches to the patient with treatment-refractory obsessive-compulsive disorder. J Clin Psychiatry 51:15-21
91. Kahn D (1990) The dichotomy of drugs and psychotherapy. Psychiat Clin North America 1990 13:197-208
92. Kahn D (1991) Medication consultation and split treatment during psychotherapy. J Am Acad Psychoanal 19:84-98
93. Kantor SJ (1990) Depression:When is psychotherapy not enough? Psychiat Clin North Am 13:241-254
94. Kapfhammer HP (1995a) Psychotherapeutische Verfahren in der Psychiatrie. Nervenarzt 66:157-172
95. Kapfhammer HP (1995b) Benzodiazepine bei Angsterkrankungen. In: Kasper S, Möller HJ (Hrsg) Angst- und Panikerkrankungen. Fischer, Jena, S 271-298
96. Kapfhammer HP (1996) Anankastische Syndrome in der Psychiatrie und ihre Therapie. In: Nissen G (Hrsg) Zwangserkrankungen.Prävention und Therapie. Huber, Bern Göttingen, S 27-42
97. Kapfhammer HP (1997) Psychotherapeutische und pharmakotherapeutische Ansätze in der Behandlung von depressiven Störungen. In: Buchheim P (Hrsg) Psychotherapie und Psychopharmaka. Störungsorientierte Behandlungsansätze - kombinierte Therapie. Schattauer, Stuttgart New York, S 31-54
98. Kapfhammer HP (1998a) Zur Interaktion von Pharmakotherapie und psychodynamischer Psychotherapie bei Patienten mit depressiven Störungen. Psychotherapie in Psychiatrie, Psychotherapeutischer Medizin und Klinischer Psychologie 3:3-13
99. Kapfhammer HP (1998b) Internistische Aspekte der Behandlung mit Antidepressiva. In: Hewer W, Lederbogen F (Hrsg) Internistische Probleme in der Psychiatrie. Enke, Stuttgart, S 53-88
100. Kapfhammer HP, Dobmeier P (1996) Psychodynamische, verhaltenstherapeutische und pharmakotherapeutische Ansätze in der Behandlung von Patienten mit Borderline-Persönlichkeitsstörungen. In: Möller HJ, Kapfhammer HP (Hrsg) Interaktion medikamentöser und psychosozialer Therapie in der Psychiatrie. Edition Pro Mente, Linz, S 99-131
101. Kapfhammer HP, Hippius H (1998) The psychopharmacological approaches in the treatment of personality disorders. J Pers Dis (in press)
102. Kaplan AH (1987) Obsessive-compulsive phenomena in adult obsessionality, compulsive personality disorder and obsessive-compulsive disorder (neurosis). Psychiatr J Univ Ottawa 145:1127-1129
103. Karasu TB (1982) Psychotherapy and pharmacotherapy:Toward an integrative model. Am J Psychiatry 139:1102-1113
104. Karasu TB (1986) The specificity versus nonspecificity dilemma:Toward identifying therapeutic change agents. Am J Psychiatry 143:687-695
105. Karasu TB (1990) Toward a clinical model of psychotherapy for depression. II:An integrative and selective treatment approach. Am J Psychiatry 147:263-278
106. Karasu TB (1992) Developmentalist metatheory of depression and psychotherapy. Am J Psychother 46:37-49
107. Karasu TB (1993) Depression:The relative merits of pharmacotherapy and psychotherapy. Curr Opin Psychiatry 6:184-190
108. Karasu TB (1995) Transtheoretical practice of psychotherapy. Am J Psychiatry 49:484-503
109. Kasper S, Möller HJ (Hrsg) (1995) Angst- und Panikerkrankungen. Fischer, Jena
110. Klerman GL (1990) The psychiatric patient's right to effective treatment:Implications of Osheroff v. Chestnut Lodge. Am J Psychiatry 147:409-418
111. Klerman GL, DiMascio A, Weissman MM (1974) Treatment of depression by drugs and psychotherapy. Am J Psychiatry 131:186-191
112. Klerman GL, Weissman MM, Rounsaville BJ, Chevron ES (1984) Interpersonal psychotherypy of depression. Basic Books, New York
113. Koenigsberg HW (1994) The combination of psychotherapy and pharmacotherapy in the treatment of borderline patients. J Psychother Pract Res 3:93-107
114. Kris AO (1989) Psychoanalysis and psychoanalytic psychotherapy. In:Michels R, Cavenar JO et al (eds) Psychiatry, chap 8. Lippincott, Philadelphia
115. Lazar SG (1997) The effectiveness of psychodynamic psychotherapy for depression. Psychoanal Inq [Suppl] 17:51-57
116. Linehan MM, Armstrong HE, Suarez A, et al (1991) Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry 48:1060-1064
117. Linehan MM, Heard HL, Armstrong HE (1993) Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Am J Psychiatry 151:1771-1776
118. Lipton MA (1983) Editorial: A letter from Anna Freud. Am J Psychiatry 140:1583-1584
119. Malan D (1979) Individual psychotherapy and the science of psychodynamics. Butterworths, London
120. Manning D, Frances A (1990) Afterword. In: Manning D, Frances A (eds) Combined pharmacotherapy and psychotherapy for depression. American Psychiatric Press, Washington, DC London, pp 183-186
121. Marazziti D, Zohar J, Cassano GB (1994) Biological dissection of obsessive compulsive disorder. In: Hollander E, Zohar J, Marazziti D, Oliver B (eds) Current insights in obsessive compulsive disorder. Wiley & Sons, Chichester, New York, pp 150-166
122. Margraf J, Barlow DH, Clark DM, Telch MJ (1993) Psychological treatment of panic: Work in progress on outcome, active ingredients, and follow-up. Behav Res Ther 31:1-8
123. Marks IM (1997) Behaviour therapy of obsessive-compulsive disorder. A decade of progress. Can J Psychiatry 42:1021-1027
124. Marks IM, Gray S, Cohen D et al (1983) Imipramine and brief therapist-aided exposure in agoraphobics having self-exposure homework. Arch Gen Psychiatry 40:153-162
125. Marks IM, Lelliot P, Basoglu M et al (1988) Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. Br J Psychiatry 152:522-534
126. Marks IM, Stern RS, Mawson D et al (1980) Clomipramine and exposure for obsessive compulsive rituals I. Br J Psychiatry 136:1-25
127. Marks IM, Swinson RP, Basoglu M et al (1993) Alprazolam and exposure alone and combined in panic disorder with agoraphobia. Br J Psychiatry 162:776-778
128. Marshall JR (1995) Integrated treatment of social phobia. Bull Menninger Clin 59 [Suppl A] 59:A27-A37
129. Mattick RP, Peters L (1988) Treatment of severe social phobia: Effects of guided exposure with and without cognitive restructuring. J Consult Clin Psychol 56:251-260
130. Mavissakalian MR (1990) The relationship between panic disorder/agoraphobia and personality disorders. Psychiatr Clin North Am 13:661-684
131. Mavissakalian MR (1993) Combined behavioral and pharmacological treatment of anxiety disorders. In: Oldham JM, Riba MB, Tasman A (eds) Review of psychiatry, vol 12. Am Psychiatric Press, Washington, DC, London, pp 565-584
132. Mavissakalian MR, Michelson L (1986a) Relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. J Clin Psychiatry 47:117-122
133. Mavissakalian MR, Michelson L (1986b) Two-year follow-up of exposure and imipramine treatment of agoraphobia. Am J Psychiatry 143:1106-1112
134. Mavissakalian MR, Michelson L, Dealy RS (1983) Pharmacological treatment of agoraphobia: Imipramine vs imipramine with programmed practice. Br J Psychiatry 143:348-355
135. Mavissakalian MR, Perel JM (1992) Clinical experiments in maintenance and discontinuation of imipramine in panic disorder with agoraphobia. Arch Gen Psychiatry 49:318-323
136. McDougle CJ (1997) Update on pharmacologic management of OCD: Agents and augmentation. J Clin Psychiatry [Suppl 12] 58:11-17
137. McLean PD (1991) Treatment choices in unipolar depression: What are the key ingredients? 21. Tagung Eur Assoc Behav Ther, Oslo
138. McLean PD, Hakistan AR (1990) Relative endurance of unipolar depression treatment effects: Longitudinal follow-up. J Consult Clin Psychol 58:482-488
139. McLean PD, Hakistan AR (1979) Clinical depression. Comparative efficacy of outpatient treatments. J Consult Clin Psychol 17:818-836
140. Miller IW, Norman WH, Keitner GI (1989) Cognitive-behavioral treatment of depressed inpatients: Six- and twelve-month follow-up. Am J Psychiatry 146:1274-1279
141. Milrod BL, Busch F, Cooper A, Shapiro T (1997) Manual of panic-focused psychodynamic psychotherapy. Am Psychiatric Press, Washington, DC, London
142. Milrod BL, Shear MK (1991a) Dynamic treatment of panic disorder: A review. J Nerv Ment Dis 179:741-743
143. Milrod BL, Shear MK (1991b) Psychodynamic treatment of panic: Three case histories. Hosp Comm Psychiatry 42:311-312
144. Modell A (1976) The"holding environment" and the therapeutic action of psychoanalysis. J Am Psychoanal Ass 24:285-307
145. Murphy GE, Simons AD, Wetzel RD et al (1984) Cognitive therapy and pharmacotherapy, singly and together, in the treatment of depression. Arch Gen Psychiatry 41:33-41
146. Nathanson DL, Pfrommer JM (1993) Affect theory and psychopharmacology. Psychiat Ann 23:584-593
147. Nevins DB (1990) Psychoanalytic perspectives on the use of medication for mental illness. Bull Menninger Clin 54:323-339
148. Oldham JM (1989) Treatment of a hysteroid-dysphoric patient. J Pers Dis 3:354-358
149. Oldham JM (1996) Combining treatment modalities. In: Neressian E, Kopff RG (eds) Textbook of psychoanalysis. Am Psychiatric Press, Washington, DC, London, pp 485-499
150. Ostow M (1962) Drugs in psychoanalysis and psychotherapy. Basic Books, New York London
151. Ostow M (1990) On beginning with patients who require medication. In: Jacobs TJ, Rothstein (eds) On beginning an analysis. Int Univ Press, Madison, CT
152. Otto MW, Gould RA, Pollack MH (1994) Cognitive-behavioral treatment of panic disorder: Considerations for the treatment of patients over the long term. Psychiatr Ann 24:307-315
153. Panel of the New York Psychoanalytic Society March 26, 1991:The use of medication with patients in analysis. J Clin Psychoanalysis 1992;1:3-55
154. Perkonigg A, Wittchen HU (1995) Epidemiologie. In: Kasper S, Möller HJ (Hrsg) Angst- und Panikerkrankungen. Fischer, Jena, pp 137-156
155. Persons JB, Thase ME, Crits-Christoph P (1996) The role of psychotherapy in the treatment of depression. Arch Gen Psychiatry 53:283-290
156. Pollack MH, Otto MW, Kaspi SP, Hammerness PG, Rosenbaum JF (1994) Cognitive therapy for treatment-refractory panic disorder. J Clin Psychiatry 55:200-205
157. Power KG, Simpson RJ, Swanson V, Wallace LA (1990) A controlled comparison of cognitive-behaviour therapy, diazepam, and placebo, alone and in combination, for the treatment of generalized anxiety disorder. J Anxiety Dis 4:267-292
158. Reimer C, Eckert J, Hautzinger M, Wilke E (1996) Psychotherapie. Ein Lehrbuch für Ärzte und Psychologen. Springer, Berlin Heidelberg New York
159. Reiser M (1996) Relationship of psychoanalysis to neuroscience. In: Neressian E, Kopff RG (eds) Textbook of psychoanalysis. Am Psychiatric Press, Washington, DC London, pp 605-633
160. Reus H W, Fischer AA, Sijben AED (1991) Cognitive-behavior therapy for major depression with melancholia. Results after twelve weeks of treatment and after six month follow-up. 21. Tagung Eur Assoc Behav Ther, Oslo
161. Roose SP (1990) The use of medication in combination with psychoanalytic psychotherapy or psychoanalysis. In: Michels R (ed) Psychiatry. Lippincott, NewYork, pp 1-8
162. Roose SP, Gabbard GO (1997) Resistance to medication during psychoanalysis. J Psychother Pract Res 6:239-248
163. Rounsaville BJ, Klerman GL, Weissman MM (1981) Do psychotherapy and pharmacotherapy for depression conflict? Empirical evidence from a clinical trial. Arch Gen Psychiatry 38:24-29
164. Rudolf G, Grande T, Porsch U (1988) Die Berliner Psychotherapiestudie. Z Psychosom Med Psychoanal 34:2-18
165. Rudolf G, Manz R, Öri C (1994) Ergebnisse psychoanalytischer Therapien. Z Psychosom Med Psychoanal 40:25-40
166. Rudolf G (1993) Psychotherapeutische Medizin. Der depressive Grundkonflikt und seine Verarbeitungen. Enke, Stuttgart, S 122-146
167. Rüger U (1979) Kombination von psychiatrischer Pharmakotherapie und Psychotherapie. Nervenarzt 50:491-500
168. Rush AJ (1985) Clinical and etiological implications of biologic dearangements in major depression. In: Davis JM, Maas JW (eds) Affective disorders American Psychiatric Press, Washington, DC, London
169. Rush AJ, Beck AT, Kovacs M, Hollon SD (1977) Comparative efficacy of cognitive therapy and pharmacotherapy in the treatment of depressed outpatients. Cognitive Ther Res 1:17-37
170. Rush AJ, Hollon SD (1991) Depression. In: Beitman BD, Klerman GL (eds) Integration of pharmacotherapy and psychotherapy. Am Psychiatric Press, Washington, DC, London, pp 121-142
171. Rush AJ, Watkins JT (1981) Group versus individual cognitive therapy: A pilot study. Cognitive Ther Res 5:95-103
172. Sarwer-Foner GJ (1960) The dynamics of psychiatric drug therapy. Thomas, Springfield, Il
173. Sarwer-Foner GJ (1983) An overview of combined psychopharmacology and psychotherapy. In: Greenhill MH (ed) Psychopharmacology and psychotherapy. Macmillan, New York, pp 165-180
174. Sarwer-Foner GJ (1987) The use of psychopharmacology in obsessive-compulsive disorders. Psychiatr J Univ Ottawa 12:197-202
175. Sarwer-Foner GJ (1993) The relationship between psychotherapy and pharmacotherapy: An introduction. Am J Psychotherapy 47:387-392
176. Scharf R (1992) In: Panel of the New York Psychoanalytic Society March 26, 1991:The use of medication with patients in analysis. J Clin Psychoanalysis 1:3-55
177. Schramm E, Berger M (1994) Zum gegenwärtigen Stand der interpersonellen Psychotherapie. Nervenarzt 65:2-10
178. Shea MT, Elkin I, Imber SD (1992) Course of depressive symptoms over follow-up: Findings from the National Institute of Mental Health treatment of depression collaborative research program. Arch Gen Psychiatry 49:792-787
179. Shear MK, Pilkonis PA, Cloitre M, Leon AC (1994) Cognitive behavioral treatment compared with nonprescriptive treatment of panic disorder. Arch Gen Psychiatry 51:395-401
180. Silvestre J, Aronowitz BR (1997) Behavioral treatment of OCD. In: Hollander E, Stein DJ (eds) Obsessive-compulsive disorders. Diagnosis, etiology, treatment. Dekker, New York, pp 225-255
181. Simon G, Ormel J, vonKorff M, Barlow W (1995) Health costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry 152:352-357
182. Smith JM (1989) Some dimensions of transference in combined treatment. In: Ellison JM (ed) The psychotherapist's guide to pharmacotherapy. Year Book Medical, Chicago, pp 79-94
183. Sotsky SM, Glass DR, Shea MT, Pilkonis PA (1991) Patient predictors of response to psychotherapy and pharmacotherapy: Findings in the NIMH treatment of depression collaborative research Programm. Am J Psychiatry 148:997-1008
184. Stein G (1992) Drug treatment of the personality disorders. Br J Psychiatry 161:167-184
185. Stevenson J, Meares R (1992) An outcome study of psychotherapy for patients with borderline personality disorder. Am J Psychiatry 149:358-362
186. Stone AA (1990) Law, science, and psychiatric malpractice: A response to Klerman's indictment of psychoanalytic psychiatry. Am J Psychiatry 147:419-427
187. Stone MH (1993) Abnormalities of personality. Within and beyond the realm of treatment. Norton, New York London
188. Strauss B, Burgmeier-Lohse M (1994) Evaluation einer stationären Langzeitgruppenpsychotherapie. Ein Beitrag zur differentiellen Psychotherapieforschung im stationären Feld. Psychother Psychosom Med Psychol 44:184-192
189. Stravynski A, Greenberg D (1992) The psychological management of depression. Acta Psychiat Scand 95:407-414
190. Teasdale JD, Fennell MJV, Hibbert GA et al (1984) Cognitive therapy for major depression disorders in primary care. Br J Psychiatry 144:400-406
191. Telch MJ, Agras WS, Jaylor CB et al (1985) Combined pharmacological and behavioral treatment for agoraphobia. Behav Res Ther 23:325-335
192. Thase ME (1997) Integrating psychotherapy and pharmacotherapy for treatment to major depressive disorder. Current status and future considerations. J Psychother Pract Res 6:300-306
193. Thase ME, Bowler K, Harden T (1991) Cognitive behavior therapy of endogenous depression: Part 2: Preliminary findings in 16 unmedicated inpatients. Behav Ther 22:469-477
194. Thase ME, Greenhouse JB, Frank E, Reynolds CF, Pilkonis PA, Hurley K, Grochocinski V, Kupfer DJ (1997) Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry 54:1009-1015
195. Thase ME, Howland R (1994) Refractory depression: Relevance of psychosocial factors and therapies. Psychiatr Ann 24:232-240
196. Thase ME, Reynolds CF, Frank E et al (1994) Response to cognitive-behavioral therapy in chronic depression. J Psychother Pract Res 3:204-214
197. Thompson EM, Brodie HKH (1980) The psychodynamics of drug therapy. Curr Psychiat Ther 20:239-251
198. Tschuschke V, Kächele H, Hölzer M (1994) Gibt es unterschiedlich effektive Formen von Psychotherapie? Psychotherapeut 39:281-297
199. Van Balkom AJLM, van Open P, Vermeulen AWA, Nauta MCE, Vorst HCM (1994) A meta-analysis on treatment of obsessive compulsive disorder: A comparison of antidepressants, behavior, and cognitive therapy. Clin Psychol Rev 14:359-381
200. van den Hout M, Arntz A, Hoeckstra R (1994) Exposure reduced agoraphobia but not panic, and cognitive therapy reduced panic but not agoraphobia. Behav Res Ther 32:447-451
201. van Oppen P, Arntz A (1994) Cognitive therapy for obsessive-compulsive disorder. Behav Res Ther 32:79-87
202. Viederman M (1989) Psychoanalysis and the use of psychoactive drugs. Bull Assoc Psychoanal Med 28:83-88
203. Waldinger PJ, Frank AF (1989) Clinician's experiences in combining medication and psychotherapy in the treatment of borderline patients. Hosp Comm Psychiatry 40:712-718
204. Waldinger RJ, Gunderson JG (1984) Completed psychotherapies with borderline patients. Am J Psychother 38:190-202
205. Weissman M, Klerman G (1991) Interpersonal psychotherapy for depression. In: Beitman BD, Klerman GL (eds) Integrating pharmacotherapy and psychotherapy. Am Psychiatric Press, Washington, DC, London, pp 379-394
206. Weissman MM, Klerman GL, Prusof BA, et al (1981) Depressed outpatients: Results one year after treatment with drugs and/or interpersonal psychotherapy. Arch Gen Psychiatry 38:51-55
207. Weissman MM, Markowitz JC (1994) Interpersonal psychotherapy. Arch Gen Psychiatry 51:599-606
208. Weissman MM, Prusoff BA, DiMasdo A (1979) The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry 136:555-558
209. Will H (1994) Zur Phänomenologie der Depression aus psychoanalytischer Sicht. Psyche 48:361-385
210. Wittchen HU, Vossen A (1995) Implikationen von Komorbidität bei Angststörungen - Ein kritischer Überblick. Verhaltenstherapie 5:120-133
211. Woodward B, Duckworth KS, Gutheil TG (1993) The pharmacotherapist-psychotherapist collaboration. In: Oldham JM, Riba MB, Tasman A (eds) Review of psychiatry, vol 12. Am Psychiatric Press, Washington, DC London, pp 631-649
212. Woollcott P (1985) Prognostic indicators in the psychotherapy of borderline patients. Am J Psychother 39:17-29
213. Wylie HW, Wylie ML (1987) An effect of pharmacotherapy on the psychoanalytic process: Case report of a modified analysis. Am J Psychiatry 144:489-492
214. Yeomans FE, Gutfreund J, Selzer MA, Clarkin JF, Hull JW, Smith TE (1994) Factors related to drop-out by borderline patients: Treatment contract and therapeutic alliance. J Psychother Pract Res 3:16-24
215. Zerbe KJ (1994) Uncharted waters: Psychodynamic considerations in the diagnosis and treatment of social phobia. Bull Menninger Clin [Suppl A] 58:A3-A20
216. Zimmer FT, Serra E, Pflug B, Heimann H (1987) Kognitive Verhaltenstherapie alleine und in Kombination mit Pharmakotherapie. In: Gerber WD, Miltner W, Mayer K (Hrsg) Verhaltensmedizin: Ergebnisse und Perspektiven interdisziplinärer Forschung. VCH Verlagsgesellschaft, Weinheim
217. Zitrin CM, Klein DF, Woerner MG (1980) Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatry 37:63-72
218. Zitrin CM, Klein DF, Woerner MG (1983) Treatment of phobias I: Comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 40:125-138
219. Zohar J, Zohar-Kadouch RC, Kindler S (1992) Current concepts in the pharmacological treatment of obsessive-compulsive disorder. Drugs 43:210-218